Follicular Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell Lymphoma

2005 ◽  
Vol 13 (4) ◽  
pp. 297-303 ◽  
Author(s):  
Megan L Troxell ◽  
Erich J Schwartz ◽  
Matt van de Rijn ◽  
Douglas T Ross ◽  
Roger A Warnke ◽  
...  
2015 ◽  
Vol 55 (2) ◽  
pp. 61-69 ◽  
Author(s):  
Haruo Ohtani ◽  
Takuya Komeno ◽  
Yoshiko Agatsuma ◽  
Motohiro Kobayashi ◽  
Masayuki Noguchi ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Daniel Benharroch ◽  
Miriam Zekzer ◽  
Karen Nalbandyan

An elderly woman presented with generalized lymphadenopathy, several systemic symptoms, and splenomegaly. An inguinal lymph node excision revealed a compound picture. One aspect of the lymph node morphology, including cells with follicular T-helper cell phenotype, was most consistent with angioimmunoblastic T-cell lymphoma. The other component, revealing spindle cells forming whorls with immunostaining for CD21, CD23, and fascin, might be an integral part of this T-cell lymphoma. However, due to the often massive involvement of the nodal tissue by these follicular dendritic cells, these areas were questionably suggestive of involvement by follicular dendritic cell sarcoma. We raise herein the issue of the borderline area between advanced follicular dendritic cell expansion in angioimmunoblastic T-cell lymphoma and a massive follicular dendritic cell proliferation consistent with follicular dendritic cells sarcoma, in the absence of a genomic analysis.


2006 ◽  
Vol 126 (2) ◽  
pp. 230-234 ◽  
Author(s):  
Cindi R. Starkey ◽  
Ayumi I. Corn ◽  
Richard S. Porensky ◽  
David Viswanatha ◽  
Carla S. Wilson

Author(s):  
Walid Shalata ◽  
Ismaell Massalha ◽  
Kayed Al-Athamen

In this report, we describe a 38-year-old male with a very rare type of lymphoma, large B cell lymphoma with T cell-rich background and nodules lacking follicular dendritic cell meshworks (THRLBCL). In 2016 the patient presented hot flashes and night sweats (B-symptoms) and peripheral edema. He was treated with R-CHOP (doxorubicin, vincristine, cyclophosphamide, rituximab and Prednisone) chemotherapy, a Positron emission tomography–computed tomography (PET-CT) scan was performed after four cycles of treatment which showed radiologic complete response and blood test (complete blood count (CBC)) results showed normal ranges. As of September, 2020 he patient remains in complete remission. We searched the literature for descriptions of cases spanning the diagnostic spectrum of THRLBCL and we identified only five cases worldwide. The last reported case was in 2014 with distinctive features that were difficult to classify according to the World Health Organization criteria or previously described variants. Our patient is the sixth case of THRLBCL to be reported. He is the youngest of the reported cases and the first from Israel and the Middle East.


2012 ◽  
Vol 74 (4) ◽  
pp. 399-404
Author(s):  
Kana KOZONO ◽  
Kazuhiko YAMAMURA ◽  
Toshihiko MASHINO ◽  
Masutaka FURUE ◽  
Hideki ASAOKU ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document